Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
暂无分享,去创建一个
A. Go | Jingrong Yang | J. Selby | J. Lo | A. Pressman | S. Feigenbaum
[1] David S. Guzick. The Polycystic Ovary Syndrome , 2007 .
[2] Judith R. Rager,et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[3] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[4] Ricardo Azziz,et al. 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .
[5] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[6] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[7] A. Dunaif,et al. Polycystic ovary syndrome: Syndrome XX? , 2003, Trends in Endocrinology & Metabolism.
[8] A. Oberg,et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[9] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[10] A. Balen,et al. What is polycystic ovary syndrome? Are national views important? , 2002, Human reproduction.
[11] M. Urbanek,et al. Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated. , 2002, Fertility and sterility.
[12] A. Dunaif,et al. Polycystic Ovary Syndrome: Diagnostic Criteria , 2002 .
[13] S. Emans,et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[14] J. Connell,et al. Altered vascular function in young women with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[15] A. Kunselman,et al. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. , 2001, The American journal of medicine.
[16] J. Manson,et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. , 2001, JAMA.
[17] J. L. San Millán,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .
[18] E. Diamanti-Kandarakis,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.
[19] T. Key,et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.
[20] A. Dunaif,et al. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.
[21] J. Selby,et al. Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population , 1997, Diabetes Care.
[22] L. Kuller,et al. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. , 1996, American journal of obstetrics and gynecology.
[23] S. Franks,et al. Polycystic ovary syndrome. , 1995, Archives of disease in childhood.
[24] N. Krieger. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.
[25] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[26] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.
[27] W. Dodson,et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.
[28] Claude Bouchard,et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .
[29] Nih Nhlbi,et al. Clinical guideline of the identificatin, evaluation, and treatment of overweight and obesity in adults , 1998 .
[30] J. Nestler,et al. 0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):1929–1935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1045 Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycysti , 2022 .